Labshake search
Citations for R&D Systems :
451 - 500 of 2659 citations for Human Chemokine Like Factor Superfamily 6 CKLFSF6 Protein since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2021Quote: ... 10 ng/mL basic fibroblast growth factor (bFGF; R&D Systems, Minneapolis, MN), 10 ng/mL epidermal growth factor (EGF ...
-
Intestinal Enteroid Monolayers Model the Human Intestinal Environment for Escherichia coli InfectionbioRxiv - Microbiology 2021Quote: ... 100 ng/mL epidermal growth factor (cat. 236-EG-200; R&D Systems), and 2 mM penicillin/streptomycin (Pen/Strep ...
-
bioRxiv - Neuroscience 2022Quote: ... 10 ng/ml platelet-derived growth factor-AA (PDGF-AA, R&D systems) and insulin-like growth factor-1 (IGF-1 ...
-
Fine tuning of CpG spatial distribution with DNA origami for improved therapeutic cancer vaccinationbioRxiv - Synthetic Biology 2023Quote: ... 20 ng/mL granulocyte-macrophage colony-stimulating factor (GM-CSF; R&D Systems) and penicillin–streptomycin ...
-
bioRxiv - Microbiology 2023Quote: ... and 50 ng/mL macrophage colony-stimulating factor (M-CSF, R&D Systems) and incubated at 37°C in 5% CO2 for 7 days.
-
bioRxiv - Neuroscience 2023Quote: ... and 5ng/ml brain-derived neurotrophic factor (BDNF) (R&D Systems, Abingdon UK). Differentiation medium was replaced every 48 hours ...
-
bioRxiv - Bioengineering 2023Quote: ... Supernatant was probed for tumor necrosis factor alpha (TNFα, R&D Systems, mta006), IL10 (Invitrogen ...
-
bioRxiv - Cancer Biology 2024Quote: ... and 20 ng/mL monocyte colony-stimulating factor (M-CSF, R&D Systems) at 37°C with 5% CO2 ...
-
bioRxiv - Bioengineering 2024Quote: ... and 10 ng/ml fibroblast growth factor-2 (R&D Systems, Minneapolis, MN). For pellet cultures ...
-
bioRxiv - Cell Biology 2020Quote: ... To induce WNT and BMP4 activation we additionally supplemented the above protocol with CHIR99021 and/or Recombinant Human BMP4 Protein (R&D Systems) (figure 3A) ...
-
bioRxiv - Cell Biology 2021Quote: GFP-binding protein (GBP) (Rothbauer et al., 2008) was fused to the Fc domain of human IgG (pIg-Tail) (R&D Systems), tagged with His6 in pET28a (EMD Biosciences) ...
-
bioRxiv - Cell Biology 2020Quote: Relative phosphorylation levels of 43 kinases and 2 related proteins were assessed using the Proteome Profiler Human Phospho-Kinase Array Kit (R&D Systems), according to the manufacturer’s instructions ...
-
bioRxiv - Bioengineering 2020Quote: ... The relative expression levels of apoptosis related proteins of post I/RI iCMs (n=3) were analyzed using the Proteome Profiler Human Apoptosis Array (ARY009, R&D Systems), according to the manufacturer’s instructions ...
-
bioRxiv - Bioengineering 2020Quote: The relative expression levels of cellular stress related proteins of iCMs (n=3) were analyzed using the Proteome Profiler Human Cell Stress Array (ARY018, R&D Systems), according to the manufacturer’s instructions ...
-
bioRxiv - Systems Biology 2019Quote: ... five µg of glycopeptide in 50 mM Tris-HCl pH 7.4 was mixed with one µg recombinant human C1GalT1/C1GalT1C1 protein (R&D Systems, NM) in the presence of either 0.5 mM UDP-Gal (Sigma-Aldrich ...
-
bioRxiv - Cancer Biology 2020Quote: ... with C-terminal 6xHis tag produced in HEK293 cells and human recombinant PD-L1-Fc chimera protein produced in mouse NS0 cells were obtained from R&D Systems, Minneapolis ...
-
bioRxiv - Cell Biology 2019Quote: GFP-binding protein (GBP) (Rothbauer et al., 2008) was fused to the Fc domain of human IgG (pIg-Tail) (R&D Systems), tagged with His6 in pET28a (EMD Biosciences) ...
-
bioRxiv - Cancer Biology 2021Quote: Effects of rSCUBE3 were investigated by treatment of osteoclast cultures with 0.25-1.25 µg/ml recombinant human rSCUBE3 protein (Cat # 7730-SC, R&D Systems, Abingdon, UK) in the presence of RANKL and M-CSF ...
-
bioRxiv - Developmental Biology 2020Quote: ... BMP4 + Activin A treatment was accomplished by treating cells with mTeSR supplemented with 3 ng/mL recombinant human BMP4 protein (R&D Systems) and 100 ng/mL recombinant human Activin A protein (R&D Systems) ...
-
bioRxiv - Immunology 2020Quote: ... non-tissue culture plates were coated overnight at 4゜C with recombinant human B7-H3 protein (R&D Systems, Minneapolis, MN) at 10 μg/well in 500 μL of PBS ...
-
bioRxiv - Cell Biology 2023Quote: ... RFP labeled eEPCs were plated with monolayer and 10ng/ml of recombinant human VEGF protein (R&D System, Cat# 293-VE-010) was treated to enhance tube formation ...
-
bioRxiv - Cancer Biology 2023Quote: ... and/or 1 μmol/L ribociclib for 48 hours and then 500 μg protein lysates were assessed using human apoptosis antibody array (#ARY009, R&D systems).
-
bioRxiv - Immunology 2023Quote: ... Levels of BAFF protein were determined in culture supernatant or bone marrow plasma using the human BAFF/BLyS/TNFSF13B DuoSet ELISA kit (R&D Systems) in combination with the Pierce Streptavidin-Poly-HRP (1:10,000 ...
-
bioRxiv - Immunology 2023Quote: ... The culture was then diluted 1:50 in 1X PBS + 1% LB broth and incubated statically at 37°C with recombinant human SLPI protein (rSLPI) (CAS: 1274-PI-100, R&D Systems) at these final concentrations ...
-
bioRxiv - Molecular Biology 2024Quote: ... Resting or ADP (10 μM)-stimulated platelets (4 × 103/μL) were pretreated with the inhibitor hDcR3 (10 μg/mL, recombinant human decoy receptor 3 protein, R&D Systems) for 10 min and then allowed to adhere to the coated coverslips for 60 min at RT under normoxic or hypoxic conditions ...
-
bioRxiv - Cancer Biology 2024Quote: ... GPC2 CAR expression was determined using APC or PE-conjugated human recombinant GPC2 protein (R&D Systems; 2304-GP-050; 1:500) and CD19 CAR using PE-tagged protein L (58036S ...
-
bioRxiv - Microbiology 2021Quote: ... bone marrow cells were cultured in RPMI-1640 medium supplemented with 10% FBS in the presence of FMS-like tyrosine kinase 3 ligand (Flt3L) (100 ng/ml, R&D Systems, Cat# 308-FK) for 7-9 days ...
-
bioRxiv - Bioengineering 2023Quote: ... human fibronectin and human recombinant BMP-2 (R&D systems, Biotechne, UK); recombinant human BMP-2 (Infuse/InductOS® Bone graft kit ...
-
bioRxiv - Neuroscience 2023Quote: ... Interleukin-6 (IL-6) levels were measured by enzyme-linked immunosorbent assay (R&D Systems, D6050). Lactate dehydrogenase (LDH ...
-
bioRxiv - Biochemistry 2020Quote: ... IL-6 (DY7984, R&D Systems), IL8 (ELL-IL8-1 ...
-
bioRxiv - Genetics 2023Quote: ... and IL-6 (R&D Systems). Normalization to the dry weight of each colonic explant was done.
-
bioRxiv - Physiology 2023Quote: ... IL-6 (R&D Systems DY406); and IL-10 (R&D Systems DY417 and Luminex) ...
-
bioRxiv - Microbiology 2024Quote: ... IL-6 (R&D Systems, DY406) and IL-1β (R&D Systems ...
-
bioRxiv - Cancer Biology 2022Quote: ... with good affinity and specificity were screened and selected from the homemade human single-chain antibody library through commercial VEGF and EGFR proteins (R&D Systems, Inc.). Then ...
-
bioRxiv - Immunology 2021Quote: The expression of NKG2D ligands in tumor cell lines was assessed using Recombinant Human NKG2D Fc Chimera Protein (R&D systems, Abingdon, UK). 105 tumor cells were incubated either with 0.5 μg of NKG2D Fc recombinant protein or IgG1-Fc during 30 min ...
-
bioRxiv - Bioengineering 2023Quote: ... The relative expression levels of apoptosis related proteins of post I/RI iCMs (n=3) were analyzed using the Proteome Profiler Human Apoptosis Array (R&D Systems, #ARY009), according to the manufacturer’s instructions.
-
bioRxiv - Physiology 2023Quote: ... ciCMVEC were placed in serum-free media 1h before treatment with 10 ng/ml of Recombinant Human TNF-α Protein (210-TA-005; R&D systems) or vehicle (PBS ...
-
bioRxiv - Bioengineering 2024Quote: ... IDUA activity was assessed using 4-methylumberlliferyl-alpha-L-iduronide (Glycosynth, Cheshire, England) and recombinant human alpha-L-iduronidase protein (R&D systems, Minneapolis) following manufacturer’s instructions.
-
bioRxiv - Systems Biology 2023Quote: Where indicated the cells were stimulated with the final concentration of 10 ng/ml of recombinant human TNF-α protein (R&D Systems) or 100 ng/ml of recombinant human interleukin 1 beta (IL-1β ...
-
bioRxiv - Biochemistry 2023Quote: ... and 250 μg of protein from each condition was incubated with a membrane array from the Proteome Profiler Human XL Cytokine Array Kit (R&D Systems, ARY022B). Membranes were processed according to the manufacturer’s instructions and imaged using an ImageQuant LAS 4000 (GE Healthcare) ...
-
bioRxiv - Microbiology 2022Quote: Secretion of CXC motif chemokine ligand 10 (CXCL10/IP-10, DY266) and CC chemokine ligand 5 (CCL5/RANTES, DY278) were quantified by DuoSet® ELISA (R&D systems, Bio-Techne GmbH, Wiesbaden, Germany) under BSL-3 conditions according to the manufacturer’s instructions using the appropriate ancillary reagent kit (DY007).
-
bioRxiv - Neuroscience 2021Quote: ... and 20 ng/ml basic fibroblast growth factor (bFGF, # 233-FB; R&D Systems) until day 24 ...
-
bioRxiv - Microbiology 2019Quote: ... 20 ng/ml epidermal growth factor (catalog number 236-EG-01M; R&D Systems), GlutaMAX (catalog number 35050061 ...
-
bioRxiv - Microbiology 2019Quote: ... 20 ng/ml fibroblast growth factor (catalog number 4114-TC-01M; R&D Systems), 20 ng/ml epidermal growth factor (catalog number 236-EG-01M ...
-
bioRxiv - Neuroscience 2021Quote: ... 0.1 ng/ml rat glial cell line-derived neurotrophic factor (GDNF; R&D systems), 1 ng/ml human brain-derived neurotrophic factor (BDNF ...
-
bioRxiv - Pathology 2021Quote: ... 1% antibiotics and 10 ng/ml basic fibroblast growth factor (bFGF) (R&D Systems). Human MPCs were trypsinized and incubated 30 min with biotinylated anti-human PDGFRα (R&D system ...
-
bioRxiv - Cell Biology 2020Quote: ... 40 ng/ml basic fibroblast growth factor (bfgf, R&D Systems, 233-FB/CF), 1X non-essential amino acids ...
-
bioRxiv - Neuroscience 2022Quote: ... and 50ng/ml tumor necrosis factor α (TNFα, R&D Systems #410-MT-025).
-
bioRxiv - Pathology 2022Quote: ... and PE-conjugated anti-Tissue Factor/CD142 (R&D Systems, polyclonal, #FAB3178P, 1/50).
-
bioRxiv - Molecular Biology 2021Quote: ... basic fibroblast growth factor (bFGF, 20 ng/mL, Cat. #4114-TC; R&D Systems), and gentamicin sulfate (50 μg/mL).